Trial
NCT06800183
Topical Tartrazine for Improved Skin Structure Visualization in Dermatology
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Healthy
Intervention
Four-Chamber Tartrazine Patch across 3 Body Sites
Why stopped
The investigators are revisiting in vitro and in vivo studies to ensure the ability to replicate the results of the original paper before proceeding to the pilot clinical study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-14